Business
Cizzle Biotechnology (CIZ): News flow driven by...
Cizzle Biotechnology (CIZ): News flow driven by....
About this update from Cizzle Biotechnology Holdings Plc
[{"type":"text","content":"\n \n\n\nHardman & Co Research\n\n\n\nHardman & Co Research: Cizzle Biotechnology (CIZ): News flow driven by deals07-Dec-2021 / 11:50 GMT/BST\n\n\nHardman & Co Research: News flow driven by deals\n\nCizzle Biotechnology (Cizzle), focused on cancer diagnostics, was spun out of the University of York to exploit the biomarker, variant CIZ1b, for early detection of different forms of lung cancer. There is high medical need for a simple blood test that allows early detection of lung cancer and potentially improve patient outcomes. Since listing, Cizzle has been considering how to develop a broader screening test that could be used to test for other cancers and developing a companion diagnostic for autoimmune disease. Cizzle continues to make progress, and has expanded the number of potential income streams through strategic partnerships.\n\nPlease click on the link below for the full report:\n\nhttps://www.hardmanandco.com/research/corporate-research/news-flow-driven-by-deals/ \n\nIf you are interested in meeting the company, you can register your interest by clicking on the above link\n\n\n To contact us:\n\n Hardman & Co1 Frederick's Place\n\n London\n\n EC2R 8AE\n\n www.hardmanandco.com\n\n Follow us on Twitter @HardmanandCo\n \n \n Contact:\n\n Martin Hall\n\n +44(0)20 3693 7075\n \n \n \n\n [email protected] \n \n Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.\n\nAbout Hardman & Co: For the past 25 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case. \n\nHardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd ...